Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 27 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (12)
P 1 (2)
P 2 (8)
P 3 (3)

Trial Status

Recruiting10
Completed9
Active Not Recruiting5
Withdrawn2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT06651632Not ApplicableActive Not RecruitingPrimary

WATER IV Prostate Cancer

NCT05155046Phase 2RecruitingPrimary

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

NCT01902680Phase 2CompletedPrimary

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

NCT07426055Phase 2Recruiting

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

NCT06966778Not ApplicableRecruitingPrimary

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

NCT06051942Not ApplicableActive Not Recruiting

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

NCT06825091Phase 3RecruitingPrimary

Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)

NCT06117059Not ApplicableRecruitingPrimary

The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance

NCT03996005Not ApplicableCompleted

MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer

NCT03814252Not ApplicableActive Not RecruitingPrimary

Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer

NCT03821246Phase 2Recruiting

Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

NCT02435472Not ApplicableCompletedPrimary

Active Surveillance Exercise Clinical Trial

NCT03315754Phase 2Active Not RecruitingPrimary

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

NCT06325774Not ApplicableRecruitingPrimary

Radical Hypofractionated Radiotherapy for Localized Prostate Cancer

NCT06325995Not ApplicableRecruitingPrimary

Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer

NCT06362577RecruitingPrimary

Clinical Study of HIFU for Localized Prostate Cancer

NCT06054867Not ApplicableActive Not RecruitingPrimary

PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

NCT05010343Phase 2RecruitingPrimary

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

NCT04225299Phase 3WithdrawnPrimary

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

NCT01931046Phase 1CompletedPrimary

Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer

Scroll to load more

Research Network

Activity Timeline